Page last updated: 2024-10-30

mesalamine and Acquired Gerstmann Syndrome

mesalamine has been researched along with Acquired Gerstmann Syndrome in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"Extraintestinal manifestations in Crohn's disease (CD) are frequent and well recognized."1.42Histologically confirmed case of cerebral vasculitis associated with Crohn's disease--a case report. ( Asaoka, K; Gekka, M; Kato, Y; Nishihara, H; Nomura, M; Sugiyama, T, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gekka, M1
Sugiyama, T1
Nomura, M1
Kato, Y1
Nishihara, H1
Asaoka, K1

Other Studies

1 other study available for mesalamine and Acquired Gerstmann Syndrome

ArticleYear
Histologically confirmed case of cerebral vasculitis associated with Crohn's disease--a case report.
    BMC neurology, 2015, Sep-21, Volume: 15

    Topics: Adalimumab; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biopsy;

2015